About LMF Redazione LaMiaFinanza.it
Redazione LMF Lamiafinanza.it. Contattaci per la pubblicazione dei tuoi comunicati alla mail [email protected]
Latest Articles
Le trastuzumab candidat biosimilaire (CT-P6) montre une efficacité et une innocuité similaires par rapport au trastuzumab de référence
Business Wire
To view full article click here
Biosimilar trastuzumab candidate, CT-P6, shown to be similar in efficacy and safety to the reference trastuzumab
Business Wire
To view full article click here
LYNPARZA™ (olaparib) Significantly Reduces the Risk of Disease Worsening or Death in Patients with BRCA-Mutated Metastatic Breast Cancer
Business Wire
To view full article click here
New Data Evaluating the Safety and Preliminary Relapse-Free Survival of Adjuvant Yervoy (ipilimumab) 3 mg/kg and 10 mg/kg in Resected High-Risk Melanoma Patients Presented at ASCO
Business Wire
To view full article click here
Zymeworks Presents Safety and Anti-Tumor Activity Data from the Ongoing Phase 1 Study of ZW25 at the American Society of Clinical Oncology Annual Meeting (ASCO 2017)
Business Wire
To view full article click here
Orbital ATK’s “S.S. John Glenn” Cygnus Departs International Space Station, Begins Secondary Mission in Space
Business Wire
To view full article click here
